80,500 XNAS Volume
XNAS 09 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 5,628 | 5,628 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 4,293 | 4,293 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 4,402 | 4,402 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 3,716 | 3,716 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 2,886 | 2,886 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 3,175 | 3,175 | - | - | Stock Options (Right to buy) | |
| Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 3,319 | 3,319 | - | - | Stock Options (Right to buy) | |
| Matthew Kiernan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 2,886 | 2,886 | - | - | Stock Options (Right to buy) | |
| Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 20,000 | 20,000 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 40,000 | 40,000 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 5,563 | 5,563 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 4,243 | 4,243 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 4,350 | 4,350 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 3,673 | 3,673 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 2,853 | 2,853 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 3,138 | 3,138 | - | - | Stock Options (Right to buy) | |
| Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 3,280 | 3,280 | - | - | Stock Options (Right to buy) | |
| Matthew Kiernan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 2,853 | 2,853 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 4,990 | 4,990 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 3,806 | 3,806 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 3,902 | 3,902 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 3,295 | 3,295 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 2,559 | 2,559 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 2,815 | 2,815 | - | - | Stock Options (Right to buy) | |
| Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 2,943 | 2,943 | - | - | Stock Options (Right to buy) | |
| Matthew Kiernan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 2,559 | 2,559 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 92,307 | 92,307 | - | - | Warrants (Right to buy) | |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 30 Sep 2024 | 92,307 | 444,491 | - | 4.7 | 438,458 | Common Stock |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 10,000 | 10,000 | - | - | Warrants (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 30 Sep 2024 | 10,000 | 40,149 | - | 4.8 | 47,500 | Common Stock |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 20,512 | 20,512 | - | - | Warrants (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 30 Sep 2024 | 20,512 | 28,949 | - | 4.8 | 97,432 | Common Stock |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 4.59 per share. | 30 Sep 2024 | 159,134 | 321,052 | - | 4.6 | 730,107 | Common Stock |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 159,134 | 159,134 | - | - | Common Stock Purchase Warrant (Right to buy) | |
| Chidozie Ugwumba | Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 424,358 | 424,358 | - | - | Warrants (Right to buy) | |
| Chidozie Ugwumba | Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 424,358 | 424,358 | - | - | Warrants (Right to buy) | |
| Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 10,000 | 10,000 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2024 | 27,320 | 27,319 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 29 Jul 2024 | 27,320 | 30,149 | - | 3 | 81,960 | Common Stock |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 65,723 | 65,723 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 900,000 | 900,000 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 2,250,000 | 2,250,000 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 2,000,000 | 2,000,000 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 800,000 | 800,000 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 50,135 | 50,135 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 51,399 | 51,399 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 43,394 | 43,394 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 33,704 | 33,704 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 37,074 | 37,074 | - | - | Stock Options (Right to buy) | |
| Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 38,760 | 38,760 | - | - | Stock Options (Right to buy) | |
| Matthew Kiernan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 33,704 | 33,704 | - | - | Stock Options (Right to buy) | |
| Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 600,000 | 600,000 | - | - | Stock Options (Right to buy) | |
| Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 400,000 | 400,000 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Matthew Kiernan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 57,488 | 57,488 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 43,853 | 43,853 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 44,959 | 44,959 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 37,957 | 37,957 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 32,429 | 32,429 | - | - | Stock Options (Right to buy) | |
| Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 33,903 | 33,903 | - | - | Stock Options (Right to buy) | |
| Matthew Kiernan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 29,481 | 29,481 | - | - | Stock Options (Right to buy) | |
| Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 400,000 | 400,000 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 900,000 | 900,000 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 800,000 | 800,000 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 26 Jun 2023 | 25,000 | 25,000 | - | 0.8 | 20,250 | Common Stock |
| John Henry Stevens | Director | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 26 Jun 2023 | 316,455 | 800,204 | - | 0.8 | 253,164 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 16 Jun 2023 | 1,500,000 | 6,793,684 | - | 0.8 | 1,200,000 | Common Stock |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 1,500,000 | 1,500,000 | - | - | Warrants (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 1,500,000 | 1,500,000 | - | - | Warrants (Right to buy) | |
| Alison H. Mosca | Director | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 16 Jun 2023 | 2,394,375 | 3,238,375 | - | 0.8 | 1,915,500 | Common Stock |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 2,394,375 | 2,394,375 | - | - | Warrants (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 2,394,375 | 2,394,375 | - | - | Warrants (Right to buy) | |
| Jonathon T. Gay | Director | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 16 Jun 2023 | 105,625 | 105,625 | - | 0.8 | 84,500 | Common Stock |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 105,625 | 105,625 | - | - | Warrants (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 105,625 | 105,625 | - | - | Warrants (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 27,628 | 27,628 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 21,075 | 21,075 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 21,607 | 21,607 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 15,585 | 15,585 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 18,950 | 18,950 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 15,585 | 15,585 | - | - | Stock Options (Right to buy) | |
| Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 125,000 | 125,000 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 75,000 | 75,000 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 15,894 | 15,894 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 12,124 | 12,124 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 12,430 | 12,430 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 8,966 | 8,966 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 9,373 | 9,373 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 9,679 | 9,679 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 8,966 | 8,966 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | 31 Dec 2022 | 1,019,210 | 5,548,019 | - | 0 | Common Stock | ||
| Reed Neil Wilcox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2022 | 174,912 | 0 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 14 Nov 2022 | 174,912 | 575,145 | - | 0.2 | 26,237 | Common Stock |
| Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 400,000 | 400,000 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 400,000 | 400,000 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 21,476 | 21,476 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 16,382 | 16,382 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 16,795 | 16,795 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 12,115 | 12,115 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 12,665 | 12,665 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 13,078 | 13,078 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 12,115 | 12,115 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 02 Nov 2022 | 2,871,287 | 5,293,684 | - | 1.0 | 2,900,000 | Common Stock |
| Alison H. Mosca | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 02 Nov 2022 | 792,079 | 844,000 | - | 1.0 | 800,000 | Common Stock |
| Jonathon T. Gay | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 02 Nov 2022 | 990,099 | 2,154,848 | - | 1.0 | 1,000,000 | Common Stock |
| John Henry Stevens | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 02 Nov 2022 | 148,515 | 483,749 | - | 1.0 | 150,000 | Common Stock |
| Chidozie Ugwumba | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 02 Nov 2022 | 990,099 | 5,518,908 | - | 1.0 | 1,000,000 | Common Stock |
| John Henry Stevens | Director | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 17 Aug 2022 | 47,662 | 335,234 | - | 3.9 | 183,499 | Common Stock |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 6,717 | 6,717 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 5,124 | 5,124 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 5,253 | 5,253 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 3,961 | 3,961 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 4,090 | 4,090 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 3,789 | 3,789 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.72 per share. | 18 Jul 2022 | 23,483 | 56,593 | - | 4.7 | 110,840 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 16 Jun 2022 | 75,000 | 2,347,787 | - | 2.5 | 187,500 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.51 per share. | 16 Jun 2022 | 74,610 | 2,422,397 | - | 2.5 | 187,271 | Common Stock |
| Mark Mortenson | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 2.47 per share. | 16 Jun 2022 | 20,247 | 168,759 | - | 2.5 | 50,010 | Common Stock |
| Alison H. Mosca | Director | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 15 Jun 2022 | 5,000 | 39,476 | - | 2.6 | 13,100 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.66 per share. | 14 Jun 2022 | 45,000 | 2,272,787 | - | 2.7 | 119,700 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.66 per share. | 14 Jun 2022 | 51,011 | 2,227,787 | - | 2.7 | 135,689 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 3.06 per share. | 13 Jun 2022 | 55,000 | 2,176,776 | - | 3.1 | 168,300 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.46 per share. | 03 Jun 2022 | 10,000 | 2,071,106 | - | 2.5 | 24,600 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.57 per share. | 03 Jun 2022 | 50,670 | 2,121,776 | - | 2.6 | 130,222 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.27 per share. | 27 May 2022 | 35,000 | 2,061,106 | - | 2.3 | 79,450 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 16 May 2022 | 181,818 | 2,026,106 | - | 2.2 | 400,000 | Common Stock |
| Robert Glanzman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 16 May 2022 | 4,717 | 10,564 | - | 2.0 | 9,576 | Common Stock |
| Jonathon T. Gay | Director | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 16 May 2022 | 10,000 | 68,745 | - | 2.1 | 20,800 | Common Stock |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 8,920 | 8,920 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 6,805 | 6,805 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 6,976 | 6,976 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 5,032 | 5,032 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 5,261 | 5,261 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 5,432 | 5,432 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 5,032 | 5,032 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2022 | 100,000 | 174,912 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 02 May 2022 | 100,000 | 400,233 | - | 0.2 | 15,000 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 3.01 per share. | 20 Apr 2022 | 132,891 | 1,844,288 | - | 3.0 | 400,002 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 28 Mar 2022 | 10,000 | 1,702,749 | - | 3.1 | 31,000 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 28 Mar 2022 | 8,648 | 1,711,397 | - | 3.2 | 27,933 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 23 Mar 2022 | 20,000 | 1,692,749 | - | 3.0 | 59,800 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.94 per share. | 23 Mar 2022 | 20,000 | 1,672,749 | - | 2.9 | 58,800 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.79 per share. | 18 Mar 2022 | 20,000 | 1,617,749 | - | 2.8 | 55,800 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 18 Mar 2022 | 35,000 | 1,652,749 | - | 2.9 | 101,500 | Common Stock |
| John Henry Stevens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 273,194 | 0 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.53 per share. | 17 Feb 2022 | 273,194 | 287,572 | - | 0.5 | 144,793 | Common Stock |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 480,000 | 480,000 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 69,652 | 69,652 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 200,000 | 200,000 | - | - | Stock Options (Right to buy) | |
| Robert Glanzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 140,000 | 140,000 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 9,701 | 9,701 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 7,400 | 7,400 | - | - | Stock Options (Right to buy) | |
| Alison H. Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 7,587 | 7,587 | - | - | Stock Options (Right to buy) | |
| Jonathon T. Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 5,473 | 5,473 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 5,721 | 5,721 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 5 | 5 | - | - | Stock Options (Right to buy) | |
| Vallerie V. McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 5,473 | 5,473 | - | - | Stock Options (Right to buy) | |
| Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 250,000 | 250,000 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 2.96 per share. | 01 Feb 2022 | 101,352 | 1,597,749 | - | 3.0 | 300,002 | Common Stock |
| Reed Neil Wilcox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2022 | 253,000 | 274,911 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 20 Jan 2022 | 253,000 | 300,233 | - | 0.2 | 37,950 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 4.93 per share. | 08 Dec 2021 | 5,000 | 1,441,397 | - | 4.9 | 24,650 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 4.87 per share. | 08 Dec 2021 | 15,000 | 1,496,397 | - | 4.9 | 73,050 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 08 Dec 2021 | 40,000 | 1,481,397 | - | 5 | 200,000 | Common Stock |
| David J. Matlin | Director | 06 Dec 2021 | 50,000 | 150,000 | - | 0.0 | 500 | Common Stock | |
| David J. Matlin | Director | 06 Dec 2021 | 50,000 | 0 | - | - | Warrants (Right to buy) | ||
| David J. Matlin | Director | 06 Dec 2021 | 12,500 | 0 | - | - | Warrants (Right to buy) | ||
| David J. Matlin | Director | 06 Dec 2021 | 12,500 | 1,436,397 | - | 0.0 | 125 | Common Stock | |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 5.26 per share. | 16 Nov 2021 | 20,000 | 1,423,897 | - | 5.3 | 105,200 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 5.71 per share. | 12 Nov 2021 | 15,000 | 1,403,897 | - | 5.7 | 85,650 | Common Stock |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 5.37 per share. | 12 Nov 2021 | 10,000 | 1,388,897 | - | 5.4 | 53,700 | Common Stock |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 5,651 | 5,651 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 100,000 | 100,000 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 200,000 | 200,000 | - | - | Stock Options (Right to buy) | |
| Robert Glanzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 100,000 | 100,000 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 4,311 | 4,311 | - | - | Stock Options (Right to buy) | |
| Alison Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 4,419 | 4,419 | - | - | Stock Options (Right to buy) | |
| Jonathon Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 3,188 | 3,188 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 3,333 | 3,333 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 3,441 | 3,441 | - | - | Stock Options (Right to buy) | |
| Vallerie McLaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 3,188 | 3,188 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 2,899 | 2,899 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 2,212 | 2,212 | - | - | Stock Options (Right to buy) | |
| Alison Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 2,267 | 2,267 | - | - | Stock Options (Right to buy) | |
| Jonathon Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 1,635 | 1,635 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 1,710 | 1,710 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 1,766 | 1,766 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 20,838 | 20,838 | - | 0 | Common Stock | |
| Alison Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 2,083 | 2,083 | - | 0 | Common Stock | |
| Jonathon Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 10,783 | 10,783 | - | 0 | Common Stock | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 14,378 | 14,378 | - | 0 | Common Stock | |
| Reed Neil Wilcox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 27,784 | 27,784 | - | 0 | Common Stock | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 80,076 | 80,076 | - | 0 | Common Stock | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 50,082 | 50,082 | - | 0 | Common Stock | |
| Robert Glanzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 15,281 | 15,281 | - | 0 | Common Stock | |
| David J. Matlin | Director | Purchase of securities on an exchange or from another person at price $ 9.63 per share. | 24 May 2021 | 207,684 | 1,378,897 | - | 9.6 | 1,999,997 | Common Stock |
| Alison Mosca | Director | Purchase of securities on an exchange or from another person at price $ 9.63 per share. | 24 May 2021 | 51,921 | 51,921 | - | 9.6 | 499,999 | Common Stock |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 3,170 | 3,170 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 2,418 | 2,418 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Alison Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 2,479 | 2,479 | - | - | Stock Options (Right to buy) | |
| Alison Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Jonathon Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Jonathon Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,788 | 1,788 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,869 | 1,869 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,930 | 1,930 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Fiona Costello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,894 | 1,894 | - | - | Stock Options (Right to buy) | |
| Fiona Costello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,788 | 1,788 | - | - | Stock Options (Right to buy) | |
| Fiona Costello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| Fiona Costello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 30,000 | 30,000 | - | - | Stock Options (Right to buy) | |
| David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | |
| Robert Etherington | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 600,000 | 600,000 | - | - | Stock Options (Right to buy) | |
| Mark Mortenson | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 200,000 | 200,000 | - | - | Stock Options (Right to buy) | |
| Robert Glanzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 95,000 | 95,000 | - | - | Stock Options (Right to buy) | |
| Shalom Jacobovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | |
| Alison Mosca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | |
| Jonathon Gay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | |
| John Henry Stevens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | |
| Reed Neil Wilcox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) | |
| Chidozie Ugwumba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 45,000 | 45,000 | - | - | Stock Options (Right to buy) |